MET Signaling Overcomes Epidermal Growth Factor Receptor Inhibition in Normal and Colorectal Cancer Stem Cells Causing Drug Resistance

Sander P.J. Joosten; Tomohiro Mizutani; Marcel Spaargaren; Hans Clevers; Steven T. Pals

doi:10.1053/j.gastro.2019.06.029

Related publications

Article2020

Hepatocyte growth factor/MET and CD44 in colorectal cancer: partners in tumorigenesis and therapy resistance

Sander P.J. Joosten, Marcel Spaargaren, Hans Clevers, Steven T. Pals

Article2023

Cancer stem cells in colorectal cancer: Signaling pathways involved in stemness and therapy resistance

Nasim Ebrahimi, Maral Afshinpour, Siavash Seifollahy Fakhr, Paniz Ghasempour Kalkhoran, Vida Shadman-Manesh, Samaneh Adelian, Sheida Beiranvand, Fatemeh Rezaei‐Tazangi, Roya Khorram, Michael R Hamblin, Amir Reza Aref

Article2024

Epidermal growth factor receptor expression and tumor immune microenvironment in pancreatic cancer

Yukiko Shibahara, Motokazu Sugimoto, Ryo Morisue, Toshihiro Suzuki, Motohiro Kojima, Genichiro Ishii, Masatoshi Kudo, S. Kobayashi, Masaru Konishi, Naoto Gotohda, Masahiro Yasunaga

Article2007

A Novel Epidermal Growth Factor Receptor Inhibitor Promotes Apoptosis in Non–Small Cell Lung Cancer Cells Resistant to Erlotinib

Thibault De La Motte Rouge, Lorenzo Galluzzi, Ken A. Olaussen, Yaël Zermati, Ezgi Tasdemir, Thomas Robert, Hugues Ripoche, Vladimir Lazar, Philippe Dessen, Francis Harper, Gérard Pierron, Guillaume Pinna, Natália de Souza Araujo, Annick Harel-Belan, Jean‐Pierre Armand, Tai W. Wong, Jean Charles Soria, Guido Guido Kroemer

Article2016

Endogenous GAS6 and Mer receptor signaling regulate prostate cancer stem cells in bone marrow

Younghun Jung, Ann M. Decker, Jingcheng Wang, Eunsohl Lee, Lulia A. Kana, Kenji Yumoto, Frank C. Cackowski, James A. Van Rhee, Peter Carmeliet, Laura Buttitta, Todd M. Morgan, Russell S. Taichman